PRESENCE OF PAF-ACETHER IN RHEUMATIC DISEASES

被引:15
|
作者
HILLIQUIN, P [1 ]
MENKES, CJ [1 ]
LAOUSSADI, S [1 ]
BENVENISTE, J [1 ]
ARNOUX, B [1 ]
机构
[1] INSERM,UNITE 200,F-92140 CLAMART,FRANCE
关键词
D O I
10.1136/ard.51.1.29
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paf-acether (paf) is a naturally occurring phospholipid involved in inflammatory processes. The presence of paf, its precursor lyso paf, and lipo-paf has been determined in blood and synovial fluid from 13 patients with rheumatoid arthritis (RA), 11 with spondylarthropathies, eight with other inflammatory rheumatisms, 13 with chondrocalcinosis, 15 with osteoarthritis, and also in blood from nine healthy subjects. Paf and lipo-paf were measured by rabbit platelet aggregation after isolation by high performance liquid chromatography, whereas lyso paf was first chemically acetylated to give paf. Lipo-paf in blood was higher in patients than in controls; lipo-paf concentrations in blood and in synovial fluid were significantly higher in rheumatoid arthritis than in osteoarthritis and chondrocalcinosis. By contrast, paf and lyso paf reached their lower values in rheumatoid arthritis. The amounts of lipid mediators were not correlated with biological parameters of inflammation. Lipo-paf, which is considered as a storage form of paf, may be the important form of paf in active inflammatory rheumatism.
引用
收藏
页码:29 / 31
页数:3
相关论文
共 50 条
  • [31] HYPOTENSIVE ACTIVITY OF PAF-ACETHER IN RATS
    CAILLARD, CG
    MONDOT, S
    ZUNDEL, JL
    JULOU, L
    [J]. AGENTS AND ACTIONS, 1982, 12 (5-6): : 725 - 730
  • [32] TRANSMEMBRANE SIGNALING AND PAF-ACETHER BIOSYNTHESIS
    NINIO, E
    JOLY, F
    [J]. LIPIDS, 1991, 26 (12) : 1034 - 1037
  • [33] INHIBITION BY THE PAF ACETHER ANTAGONIST 48740 RP OF THE BRONCHOPULMONARY EFFECTS OF PAF-ACETHER
    DESQUAND, S
    LEFORT, J
    DEREGNAUCOURT, J
    SEDIVY, P
    LAGENTE, V
    RANDON, J
    VARGAFTIG, BB
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (03): : 383 - 383
  • [34] INTERFERENCE OF PAF-ACETHER ANTAGONISTS WITH THE HYPERRESPONSIVENESS TO PAF-ACETHER OF LUNGS FROM ACTIVELY SENSITIZED GUINEA-PIGS
    PRETOLANI, M
    LEFORT, J
    VARGAFTIG, BB
    [J]. PROSTAGLANDINS, 1988, 35 (05): : 800 - 800
  • [35] PRESENCE OF PAF-ACETHER IN HUMAN-BREAST CANCER-TISSUE
    PITTON, C
    BOUGNOUX, P
    LANSON, M
    BENVENISTE, J
    [J]. FEDERATION PROCEEDINGS, 1987, 46 (04) : 1506 - 1506
  • [36] PAF-ACETHER SPECIFIC BINDING-SITES .1. QUANTITATIVE SAR STUDY OF PAF-ACETHER ISOSTERES
    GODFROID, JJ
    BRAQUET, P
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (09) : 368 - 373
  • [37] IS THERE A CASE FOR PAF-ACETHER ANTAGONISTS - INTRODUCTION
    不详
    [J]. PROSTAGLANDINS, 1985, 30 (04): : 684 - 685
  • [38] PAF-ACETHER - A MEDIATOR OF INFLAMMATION AND ASTHMA
    PAGE, CP
    ARCHER, CB
    PAUL, W
    MORLEY, J
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (06) : 239 - 241
  • [39] BIOSYNTHESIS OF PAF-ACETHER .13. PAF-ACETHER BUT NOT LEUKOTRIENE-C-4 PRODUCTION IS IMPAIRED IN CULTURED MACROPHAGES
    DULIOUST, A
    VIVIER, E
    MESLIER, N
    ROUBIN, R
    HAYELEGRAND, I
    BENVENISTE, J
    [J]. BIOCHEMICAL JOURNAL, 1989, 263 (01) : 165 - 171
  • [40] RELEASE OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER) AND LYSO PAF-ACETHER FROM ISOLATED KIDNEY-CELLS
    PIROTZKY, E
    BIDAULT, J
    BENVENISTE, J
    [J]. FEDERATION PROCEEDINGS, 1982, 41 (03) : 820 - 820